Electrospun Nanofibers in Oral Drug Delivery

被引:122
作者
Ignatious, Francis [1 ]
Sun, Linghong [1 ]
Lee, Chao-Pin [2 ]
Baldoni, John [1 ]
机构
[1] GlaxoSmithKline, Pharmaceut Dev, Collegeville, PA 19426 USA
[2] GlaxoSmithKline, R&D China, Pharmaceut Sci, Shanghai 201203, Peoples R China
关键词
bioavailability; drug delivery; electrospinning; nanofiber; solubility; SOLID DISPERSION; POLYMER; EXCIPIENTS;
D O I
10.1007/s11095-010-0061-6
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
In order to enhance the delivery of drugs with limited absorption due to poor solubility/dissolution, approaches are being developed to improve the dissolution rates and solubility of drug molecules. These approaches include identification of water-soluble salts of parent drugs, preparation of stable amorphous drug formulations, inclusion of solubility-enhancing agents in the dosage form, and particle size reduction. Technologies to reduce drug particle size to sub-micrometer range are being applied to product development more frequently. Electrospinning is being considered as one of the technologies which can produce nanosized drugs incorporated in polymeric nanofibers. In vitro and in vivo studies have demonstrated that the release rates of drugs from these nanofiber formulations are enhanced compared to those from original drug substance. This technology has the potential to be used for enhancing the oral delivery of poorly soluble drugs.
引用
收藏
页码:576 / 588
页数:13
相关论文
共 28 条
[1]   A THEORETICAL BASIS FOR A BIOPHARMACEUTIC DRUG CLASSIFICATION - THE CORRELATION OF IN-VITRO DRUG PRODUCT DISSOLUTION AND IN-VIVO BIOAVAILABILITY [J].
AMIDON, GL ;
LENNERNAS, H ;
SHAH, VP ;
CRISON, JR .
PHARMACEUTICAL RESEARCH, 1995, 12 (03) :413-420
[2]  
[Anonymous], [No title captured]
[3]  
[Anonymous], [No title captured], Patent No. 0154667
[4]   Pain management in osteoarthritis: A focus on onset of efficacy - A comparison of rofecoxib, celecoxib, acetaminophen, and nabumetone across four clinical trials [J].
Battisti, WP ;
Katz, NP ;
Weaver, AL ;
Matsumoto, AK ;
Kivitz, AJ ;
Polis, AB ;
Geba, GP .
JOURNAL OF PAIN, 2004, 5 (09) :511-520
[5]   A comparison of alternative polymer excipients and processing methods for making solid dispersions of a poorly water soluble drug [J].
Broman, E ;
Khoo, C ;
Taylor, LS .
INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2001, 222 (01) :139-151
[6]  
CUMMINGS P, 2001, Patent No. 0113889
[7]   Improved oral drug delivery: Solubility limitations overcome by the use of prodrugs [J].
Fleisher, D ;
Bong, R ;
Stewart, BH .
ADVANCED DRUG DELIVERY REVIEWS, 1996, 19 (02) :115-130
[8]  
Formhals A, 1938, Method and apparatus for the production of fibers, Patent No. [2116942, US2116942]
[9]  
Habib M., 2001, PHARM SOLID DISPERSI, V1st
[10]   COMPARISON OF POLYETHYLENE-GLYCOL AND POLYOXYETHYLENE STEARATE AS EXCIPIENTS FOR SOLID DISPERSION-SYSTEMS OF GRISEOFULVIN AND TOLBUTAMIDE .1. PHASE-EQUILIBRIA [J].
KAUR, R ;
GRANT, DJW ;
EAVES, T .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1980, 69 (11) :1317-1321